Clinical trial
Preoperative Daptomycin Prophylaxis for Preventing Gram-Positive or Methicillin-Resistant Staphylococcus Aureus Infection in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
NCT06189885 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Daptomycin Prophylaxis for Preventing Gram-Positive or Methicillin-Resistant Staphylococcus Aureus Infection in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2024
- Completion date
- July 31, 2026
- Enrollment
- 184 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
periprosthetic joint infection